Has Tasneem Hasan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,342 in general payments to Tasneem Hasan, MD across 359 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tasneem Hasan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tasneem Hasan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tasneem Hasan, MD

Neurology · Lapeer, MINPI 1801393566

Payments from drug & device makers

$7,342in general payments, 2019–2025

Across 359 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$642
AstraZeneca$610
UCB, Inc.$609
Pfizer$504
Novartis$410
Biogen$406
plus $4K from 27 others

What the payments were for

Food & beverage$7,23799%
Education$1051%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	51	$642
AstraZeneca(2 entities)	13	$610
UCB, Inc.	39	$609
Pfizer	31	$504
Novartis	20	$410
Biogen	16	$406
Amgen	24	$394
Neurelis, Inc.	14	$351
Teva Pharmaceuticals USA, Inc.	12	$334
Genentech USA, Inc.	15	$295
Eisai Inc.	10	$247
Lilly USA, LLC	13	$237
Acadia Pharmaceuticals Inc	10	$237
Jazz Pharmaceuticals Inc.	10	$211
Bristol Myers Squibb	11	$194
Neurocrine Biosciences, Inc.	8	$174
TG Therapeutics, Inc.	6	$171
Aucta Pharmaceuticals, Inc.	8	$150
Otsuka America Pharmaceutical, Inc.	7	$141
SK Life Science, Inc.	5	$131
Catalyst Pharmaceuticals, Inc.	6	$128
GSK	1	$125
Kyowa Kirin, Inc.	6	$118
Lundbeck LLC	4	$110
Argenx US, Inc.	4	$89
Biohaven Pharmaceutical Holding Company Ltd.	3	$65
Sanofi	2	$57
Tanabe Pharma America, Inc.	2	$50
CSL Behring	2	$41
Chiesi USA, Inc.	2	$40
EMD Serono, Inc.	2	$28
Medtronic	1	$25
Axsome Therapeutics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,342 in reported general payments places this provider in the 70th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan →

Medicare billing

Part B allowed, 2024

$152,334

Medicare patients

367

Services billed

1,315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lacosamide	45	$1,737
Donepezil Hcl	180	$1,633
Levetiracetam	67	$1,508
Memantine Hcl	105	$1,477
Primidone	55	$1,114
Gabapentin	101	$965
Carbidopa-LevodopaCarbidopa/Levodopa	45	$906
RivastigmineRivastigmine Tartrate	16	$511
Duloxetine Hcl	42	$410
Pramipexole DihydrochloridePramipexole Di-Hcl	24	$369
Topiramate	29	$352
Carbidopa-Levodopa ErCarbidopa/Levodopa	12	$346
Nortriptyline Hcl	39	$185
Pregabalin	13	$123
Celecoxib	11	$105

Paid to pharmacies, not to this prescriber.

Other neurology in Lapeer

Aaron EllenbogenFarmington Hills$14.5M
Martin BelkinFarmington Hills$5.8M
Evanthia BernitsasDetroit$4.8M
Yang Mao DraayerFarmington Hills$4.2M
Mirela CerghetDetroit$3.8M
Peter le WittWest Bloomfield$3.2M
Judith HeidebrinkAnn Arbor$2.2M
Denise LeungAnn Arbor$2M
Rany AburashedOwosso$1.9M
Jeanie CoteOwosso$1.8M

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →